- Home
- CLRO vs VYNE Comparison
CLRO vs VYNE Comparison
Compare CLRO & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRO
- VYNE
- Stock Information
- Founded
- CLRO 1983
- VYNE 2003
- Country
- CLRO United States
- VYNE United States
- Employees
- CLRO N/A
- VYNE N/A
- Industry
- CLRO Radio And Television Broadcasting And Communications Equipment
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- CLRO Technology
- VYNE Health Care
- Exchange
- CLRO Nasdaq
- VYNE Nasdaq
- Market Cap
- CLRO 9.3M
- VYNE 7.9M
- IPO Year
- CLRO N/A
- VYNE 2018
- Fundamental
- Price
- CLRO $5.77
- VYNE $0.41
- Analyst Decision
- CLRO
- VYNE Buy
- Analyst Count
- CLRO 0
- VYNE 2
- Target Price
- CLRO N/A
- VYNE $8.00
- AVG Volume (30 Days)
- CLRO 53.0K
- VYNE 2.6M
- Earning Date
- CLRO 11-14-2025
- VYNE 11-06-2025
- Dividend Yield
- CLRO N/A
- VYNE N/A
- EPS Growth
- CLRO N/A
- VYNE N/A
- EPS
- CLRO N/A
- VYNE N/A
- Revenue
- CLRO $9,689,000.00
- VYNE $476,000.00
- Revenue This Year
- CLRO N/A
- VYNE N/A
- Revenue Next Year
- CLRO N/A
- VYNE N/A
- P/E Ratio
- CLRO N/A
- VYNE N/A
- Revenue Growth
- CLRO N/A
- VYNE N/A
- 52 Week Low
- CLRO $3.83
- VYNE $0.28
- 52 Week High
- CLRO $21.00
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- CLRO 61.93
- VYNE 57.89
- Support Level
- CLRO $5.53
- VYNE $0.32
- Resistance Level
- CLRO $6.14
- VYNE $0.35
- Average True Range (ATR)
- CLRO 0.46
- VYNE 0.02
- MACD
- CLRO 0.06
- VYNE 0.02
- Stochastic Oscillator
- CLRO 44.17
- VYNE 92.82
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.